Additionally, the use of TGF-β inhibitors (SB-431542) and si-smad2 has been demonstrated to effectively mitigate the excessive proliferation and colony formation of NSG1-induced ESCC cells (Fig. 3H, I). Here, TGFB1 is linked to esophageal squamous cell carcinoma.